Navigation Links
Aspirin to Prevent Deafness caused by Antibiotics

A recent study has shown that aspirin when taken along with gentamycin can prevent the latter’s side effect- permanent hearing loss//.

The results of the study are especially important in the developing countries where the amino glycosides family of antibiotics, which includes gentamycin, is commonly used due to their low cost and ready availability.

The study has been published in this week's New England Journal of Medicine. The University of Michigan and the Fourth Military Medical University in Xi’an, China jointly conducted the research.

According to Jochen Schacht of the University of Michigan, co-author of the study of the millions of people consuming the drug worldwide, hearing loss has been reported in at least 1 in 10 persons.

Gentamycin does not have much popularity in United States because of its widely publicized risks.

Schacht and his colleague Su-Hua Sha conducted their aspirin tests in China because the problem was seen there especially among children.

The tests revealed that only 3 percent of the 89 patients treated with gentamycin along with 3 grams of aspirin a day developed hearing problems five weeks after treatment in contrast to the 13 percent of the 106 who got a placebo in addition to the antibiotic.

According to researchers the ability of Aspirin to absorb oxidants may be the reason why it works and probably other antioxidant drugs could work as well. However aspirin was simpler in use and quite inexpensive.

The World Health Organization recommends amino glycosides especially for cases of drug-resistant tuberculosis. An inhaled form of gentamycin is also often recommended to patients with cystic fibrosis. Its effect on hearing comes from the destruction of the tiny hairs in the inner ear whose job is to detect sounds at different frequencies.

Researchers found that aspirin did not decrease the action of the antibiotic although some stomach problems were reported in a few patients.

The Sha team still considers the benefits to outweigh the risks.


'"/>




Related medicine news :

1. What happens when Asthmatics consume Aspirin?
2. Aspirin reduces deaths
3. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
4. Aspirin - a drug after one’s own hear
5. Aspirin deflated
6. Aspirin surpasses Modern Anti-clotting Drugs
7. Night Time Aspirin Regimen Found to Reduce Blood Pressure
8. Aspirin Lowers Leukemia Risk
9. Aspirin usage linked with pancreatic cancer
10. Aspirin Found To Reduce The Risk Of Colon Cancer
11. Aspirin Induced Asthma , A Little-Known Inducer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: